Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases

scientific article published on 15 April 2020

Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJSO.2020.04.019
P698PubMed publication ID32354538

P2093author name stringH J Guchelaar
J J Swen
H Gelderblom
I H J T de Hingh
R J Lurvink
T van Wezel
M J Deenen
S Böhringer
E C Hulshof
N Caserta
P921main subjectbiomarkerQ864574
peritoneal carcinomatosisQ2071182
P577publication date2020-04-15
P1433published inEuropean Journal of Surgical OncologyQ2345728
P1476titleIdentification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases

Search more.